D. E. Shaw & Co., Inc. Haemonetics Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $8.52 Million - $10.2 Million	104,849 Added 296.06%	140,264 $11.6 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $510,078 - $611,106	7,160 Added 25.34%	35,415 $3.02 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $92,920 - $106,779	-1,153 Reduced 3.92%	28,255 $2.42 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $136,306 - $154,351	1,651 Added 5.95%	29,408 $2.63 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $6,628 - $7,334	-82 Reduced 0.29%	27,757 $2.36 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $2.03 Million - $2.52 Million	27,839 New	27,839 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $2.08 Million - $2.58 Million	-32,820 Reduced 80.41%	7,998 $592,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $6.57 Million - $8.81 Million	-133,304 Reduced 76.56%	40,818 $2.66 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $726,100 - $1.05 Million	-16,589 Reduced 8.7%	174,122 $11 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $3.41 Million - $5.14 Million	-68,911 Reduced 26.54%	190,711 $10.1 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $14.8 Million - $18.1 Million	-256,145 Reduced 49.66%	259,622 $18.3 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $20.7 Million - $47.4 Million	399,381 Added 343.15%	515,767 $34.4 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $8.79 Million - $11 Million	79,166 Added 212.7%	116,386 $12.9 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $18.4 Million - $24.9 Million	-207,222 Reduced 84.77%	37,220 $4.42 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $9.8 Million - $12.1 Million	129,566 Added 112.79%	244,442 $21.3 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $1.32 Million - $1.85 Million	15,591 Added 15.7%	114,876 $10.3 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $229,636 - $376,301	-3,089 Reduced 3.02%	99,285 $9.9 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $8.56 Million - $9.69 Million	74,825 Added 271.61%	102,374 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $6.95 Million - $8.21 Million	-59,303 Reduced 68.28%	27,549 $3.48 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $15 Million - $22.1 Million	-183,756 Reduced 67.9%	86,852 $10.5 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $2.58 Million - $3.17 Million	31,037 Added 12.96%	270,608 $23.7 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $7.94 Million - $10.2 Million	-87,525 Reduced 26.76%	239,571 $24 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $6.32 Million - $8.05 Million	-70,225 Reduced 17.67%	327,096 $37.5 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $24.8 Million - $33.2 Million	346,415 Added 680.5%	397,321 $35.6 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $1.85 Million - $2.26 Million	30,398 Added 148.23%	50,906 $3.72 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $4 Million - $5.25 Million	-88,930 Reduced 81.26%	20,508 $1.19 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $4.42 Million - $4.91 Million	109,438	109,438 $4.91 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$450 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$390 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$335 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$317 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$304 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account